Biologics Market Growth & Trends 2025 to 2035

Future Market Insights

Biologics Market

Key Insight

Monoclonal antibodies will lead biologics sales through 2035 with 65.1% share of the drug class segment in 2025. Oncology holds 32.4% share of the application segment in 2025. The market is expected to reach USD 450.2 billion in 2025 and USD 1,077.2 billion by 2035 across major therapy areas.

July 01, 2025

Anurag Sharma

250 Pages

Cite this Report

Biologics Market

https://www.futuremarketinsights.com/reports/biologics-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

The Vanguard Group
Amgen
Biocon Ltd
Eli Lilly and Company
GSK
Moderna TX
Novartis
Novavax Inc
L'Oréal

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Biologics Market

Key Players

Similar Industry Reports